跳至主要内容
临床试验/ITMCTR1900002665
ITMCTR1900002665招募中4 期

Clinical study for Intervention of compound Xueshuantong Capsule on the incidence of heart failure in patients with acute myocardial infarction after PCI based on the combination of disease and syndrome

The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1. The patients with acute myocardial infarction within 12 hours, underwent emergency PCI, or underwent PCI after emergency thrombolytic therapy;
  • 2. The patients meet the syndrome differentiation standard of TCM with Deficient Qi and Yin combined blood stasis;
  • 3. Aged 18 to 75 years, both men and women;
  • 4. Sign the informed consent voluntarily.

排除标准

  • 1. Stable angina or unstable angina;
  • 2. Acute myocardial infarction with heart failure, Killip classification II, III or IV;
  • 3. Acute myocardial infarction with severe complications, such as cardiogenic shock(conventional treatment cannot correct), or mechanical complication;
  • 4. Severe arrhythmia, such as Rapid atrial fibrillation, ventricular tachycardia, high atrioventricular block, etc.
  • 5. Chronic heart failure or old myocardial infarction in the past medical history;
  • 6. Combined with other diseases, such as cardiomyopathy, rheumatic heart disease, severe valvular heart disease, cardiac tamponade, hypertension emergency, pulmonary arterial hypertension, acute paroxysmal asthma /COPD, severe infection , and so on;
  • 7. Patients with severe liver and kidney function impairment (ALT >3 times the upper limit of normal reference value, or Cr >= 3mg/dL or eGFR<= 60ml/min1.73m2); and with severe primary diseases such as endocrine or hematopoietic system; and with mental diseases;
  • 8. Patients with malignant tumor;
  • 9. Allergic constitution or allergy to multiple drug or food, allergy to known components of the study drugs;
  • 10. Cannot take care of themselves and cannot receive oral drug;
  • 11. Participated in other drug clinical trials within 3 month;
  • 12. Suspecting or ensuring with a history of substance abuse alcohol or drug abuse;
  • 13. Pregnant or lactating women, or planned pregnancy;
  • 14. Patients with cerebral vascular accidents, major surgery and trauma recently.

研究者

发起方
The First Affiliated Hospital of Guangzhou University of Chinese Medicine

相似试验